Bupropion: Enhancing Sleep Without Sacrificing Quality

does bupropion increase sleep without decreasing quality

Bupropion is an atypical antidepressant that has been observed to have a positive impact on sleep quality in patients with depression. It is one of the more frequently prescribed antidepressants, ranking fourth, and is generally well-tolerated. However, concerns about potential side effects such as anxiety, insomnia, and seizures have impacted its popularity. This paragraph will explore the question: does bupropion increase sleep without decreasing quality?

Characteristics Values
Effect on sleep quality Increases REM latency, does not suppress REM sleep, does not impact PSG sleep continuity and architecture
Effect on VLFC May increase vulnerability to cardiovascular disease in some depressed patients
Effect on stable-unstable sleep transitions May indicate vulnerability to cardiovascular disease
Effect on insomnia May cause insomnia, but the difference is very small
Effect on energy Positive effect on energy
Effect on seizures Higher risk of causing seizures, particularly in patients with bulimia
Effect on blood pressure May increase diastolic blood pressure
Effect on sedation Does not produce sedation
Effect on sleepiness May be suited for depressed patients with fatigue and sleepiness
Effect on agitation May cause agitation
Effect on anxiety May cause anxiety
Effect on dizziness May cause dizziness
Effect on alertness May cause drowsiness and reduced alertness
Effect on cardiovascular disease May increase vulnerability to cardiovascular disease

shunsleep

Bupropion can be used to treat severe morning sleep inertia

Bupropion is a unique antidepressant that can be used to treat severe morning sleep inertia. It is a second-generation antidepressant that entered the market in 1985 and was soon associated with a high rate of seizures, particularly in patients with bulimia. It was withdrawn and rereleased in 1989 with a lower maximum dosage of 450 mg per day. Bupropion is one of the more frequently prescribed antidepressants, ranking fourth, and is well tolerated, although concerns about anxiety, insomnia, and seizures have affected its popularity.

Bupropion has wake-promoting properties and can diminish fatigue and somnolence during the day. It does not suppress REM sleep, nor does it disturb sleep architecture or increase periodic limb movements. It is also used to treat restless leg syndrome. It can produce a sense of wellbeing and increased energy in patients. However, it may also cause agitation, irritability, and abnormal behaviors, as well as increased blood pressure, dizziness, and blurred vision.

A study on four patients with severe morning sleep inertia found that bedtime long-acting bupropion, along with long-acting methylphenidate, was effective in treating the condition. Severe morning sleep inertia is a chronic condition with adverse effects on functioning and quality of life, and there is currently no recognized therapy for it. The condition is marked by impaired performance, reduced vigilance, a strong desire to return to sleep, and sometimes behavioral abnormalities. Bupropion's activation effects and lack of sedation make it well-suited for treating this condition.

Bupropion should not be taken too close to bedtime as it may cause insomnia. It is important to consult a doctor before taking bupropion and to follow their instructions regarding dosage and timing. Drinking alcohol should be limited or avoided while taking bupropion to prevent seizures.

shunsleep

Bupropion is associated with insomnia as a side effect

Bupropion is a widely prescribed antidepressant used to treat major depressive disorder, seasonal affective disorder, tobacco cessation, and attention-deficit/hyperactivity disorder. While it is generally well-tolerated, it has been associated with insomnia as a side effect.

Insomnia is one of the most commonly reported side effects of bupropion, with clinical research indicating that 11% to 20% of people taking the medication experience insomnia. This is notably higher than the 4% to 7% incidence rate in individuals taking a placebo. The risk of insomnia is influenced by the formulation and timing of bupropion administration. The immediate-release (IR) and sustained-release (SR) formulations have been associated with a higher risk of insomnia compared to the extended-release (XL) dosage form. This is due to differences in the pharmacokinetics of the formulations, with the IR and SR dosages resulting in multiple daily peak exposures, while the XL dosage provides a single daily peak exposure later in the day.

Additionally, the alerting effects of bupropion can disrupt sleep, particularly when short-acting formulations are administered later in the day. Bupropion's wake-promoting properties can diminish fatigue and somnolence during the day, but they may also contribute to insomnia. However, it is important to note that bupropion does not suppress REM sleep and has been found to improve sleep quality in individuals with depression.

The side effects of bupropion typically emerge early on in the treatment, often within the first few days. Other common side effects include agitation, headaches, weight changes, and sexual dysfunction. While less common, serious side effects such as seizures and suicidal thoughts can also occur. To minimise these side effects, patients are advised to follow their prescription accurately, report all medical conditions and medications, avoid alcohol, and consult their healthcare providers for guidance.

shunsleep

Bupropion does not impact PSG sleep continuity

While bupropion is one of the better-tolerated antidepressants, it has been associated with anxiety, insomnia, and seizures. Bupropion is a unique antidepressant that inhibits the reuptake of norepinephrine and dopamine in the central nervous system, which accounts for its activation effects. It does not suppress REM sleep, nor does it disturb sleep architecture or increase periodic limb movements.

Evidence from RCTs suggests that bupropion does not impact PSG sleep continuity and architecture in patients with depression. This is supported by a recent retrospective study on a large cohort of patients with insomnia and chronic fatigue syndrome, where bupropion was one of the few antidepressants not associated with a decrease in REM sleep.

A study by Ott et al. (2004) found that while bupropion lengthened REM latency, it did not affect PSG sleep continuity or non-REM sleep architecture. This is in contrast to other antidepressants, which tend to worsen sleep quality by increasing REM latency, REM density, and reducing restorative slow-wave sleep.

Bupropion's wake-promoting properties can diminish fatigue and somnolence during the day, but it is associated with insomnia as a side effect. However, it is important to note that bupropion can treat restless leg syndrome, which is a side effect of other second-generation antidepressants.

shunsleep

Bupropion may cause drowsiness

Bupropion is an atypical antidepressant that has been observed to have a positive effect on energy levels. It is one of the more frequently prescribed antidepressants, although concerns about anxiety, insomnia, and seizures have somewhat dampened its popularity.

Bupropion is associated with insomnia as a side effect, and it is known to carry a higher risk of causing initiation insomnia than other antidepressants. However, it is important to distinguish between sleep quality and insomnia. While bupropion may cause insomnia, it has been found to improve sleep quality.

Bupropion has been found to increase REM latency, which means that the patient enters REM sleep too quickly. It also increases REM density and reduces the restorative slow-wave sleep. However, it does not suppress REM sleep, nor does it disturb sleep architecture or increase periodic limb movements. In fact, bupropion can treat restless leg syndrome, which is a side effect of other antidepressants.

Bupropion is also unique in that it simultaneously and selectively inhibits the reuptake of norepinephrine and dopamine in the central nervous system, which accounts for its activation effects. This makes it ideal for depressed patients with fatigue, anergia, and/or sleepiness. Furthermore, its lack of affinity for serotonergic, histaminergic, and cholinergic receptors contributes to its lack of sedation.

Despite the benefits of bupropion, it may cause drowsiness in some people. It is important to know how you react to this medicine before engaging in activities that require alertness, such as driving or operating machinery. If you experience drowsiness while taking bupropion, consult your doctor.

shunsleep

Bupropion may increase vulnerability to cardiovascular disease

While bupropion is one of the better-tolerated antidepressants, it has been associated with concerns about anxiety, insomnia, and seizures. Bupropion is an atypical antidepressant that influences the central and autonomic nervous systems. In a study of 58 subjects with major depressive disorder, bupropion produced small increases in diastolic blood pressure, suggesting that it may have mild cardiovascular side effects.

Bupropion has wake-promoting properties and can diminish fatigue and somnolence during the day. It is associated with insomnia as a side effect, and evidence from RCTs suggests that it increases REM latency. However, it does not suppress REM sleep nor impact PSG sleep continuity and architecture in patients with depression.

Bupropion's effects on sleep may be related to its influence on the central and autonomic nervous systems. REM sleep has the lowest cardiorespiratory phase synchronization, indicating elevated cardiovascular risk. Increased stable-unstable sleep transitions may indicate vulnerability to cardiovascular disease, likely due to enhanced sympathetic and decreased parasympathetic tone.

While bupropion did not adversely affect supine or standing blood pressure in patients without cardiovascular disease, it did cause a rise in supine blood pressure in patients with preexisting cardiovascular disease. Bupropion treatment was discontinued for 14% of patients due to adverse effects, including exacerbation of baseline hypertension in two patients.

In summary, while bupropion is generally well-tolerated and may have positive effects on energy and sleep quality, it may increase vulnerability to cardiovascular disease in some individuals, particularly those with preexisting cardiovascular conditions. Further studies are needed to confirm these findings and fully understand the cardiovascular profile of bupropion.

Frequently asked questions

Bupropion is an atypical antidepressant that can increase sleep. It is one of the better-tolerated antidepressants and does not disturb sleep architecture.

Bupropion does not decrease sleep quality. It is associated with insomnia as a side effect and can cause drowsiness in some people, but it does not suppress REM sleep.

Bupropion may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause suicidal thoughts, increased depression, or seizures. It can also cause an increase in blood pressure.

Bupropion can be used to treat severe morning sleep inertia and restless leg syndrome. It can also be used to prevent depression with seasonal affective disorder.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment